SEC 13F Intelligence

Boxer Capital, LLC / KYMR

Boxer Capital, LLC’s Kymera Therapeutics Inc Position

Does Boxer Capital, LLC own Kymera Therapeutics Inc (KYMR)? Not currently — the last reported position was 450.0K shares worth $21M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$21M
Q3 2024
Shares
450.0K
% of Portfolio
+1.05%
Quarters Held
1
position exited

Position History KYMR

Reported value by quarter
Q3 ’24: $21MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024450.0K$21M+1.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of KYMR.